| |
| |
|
| Insider
Information: |
Patton John Stuart |
| Relationship: |
Chief Scientific Offic... |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
493,756 |
|
|
Indirect Shares
|
233,444 |
|
|
| Direct
Value |
$8,314,078 |
|
|
|
Indirect Value
|
$10,047,695 |
|
|
| Total
Shares |
727,200 |
|
|
| Total
Value |
$18,361,773 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
Director |
2014-08-19 |
179,876 |
2005-01-18 |
232,830 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Chief Scientific Offic... |
2008-11-14 |
313,880 |
2006-05-15 |
614 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
63 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2004-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
83,051 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2004-03-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
232,830 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
83,051 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
232,830 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2008-11-14 |
4 |
S |
$4.37 |
$3,321 |
D/D |
(760) |
313,880 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2007-01-05 |
4 |
OE |
$14.52 |
$14,520 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-03-14 |
4 |
S |
$14.37 |
$21,368 |
I/I |
(1,487) |
534,878 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2006-05-15 |
4 |
S |
$20.21 |
$33,003 |
I/I |
(1,633) |
614 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-05-10 |
4 |
S |
$14.47 |
$25,323 |
I/I |
(1,750) |
1,621 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2008-11-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,500 |
314,640 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2007-05-14 |
4 |
A |
$0.01 |
$30 |
D/D |
3,000 |
311,864 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-12-15 |
4 |
S |
$19.42 |
$66,033 |
I/I |
(3,400) |
2,211 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2006-03-07 |
4 |
S |
$19.80 |
$76,390 |
I/I |
(3,859) |
558,131 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2004-12-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,030 |
503,278 |
|
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2005-03-14 |
4 |
A |
$0.00 |
$0 |
I/I |
4,166 |
539,044 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-06-26 |
4 |
AS |
$8.93 |
$73,643 |
D/D |
(8,200) |
112,471 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-03-15 |
4 |
AS |
$8.00 |
$68,800 |
D/D |
(8,600) |
337,471 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2006-03-03 |
4 |
A |
$0.01 |
$103 |
I/I |
10,333 |
561,990 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-06-26 |
4 |
AS |
$8.42 |
$102,177 |
D/D |
(11,800) |
120,671 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Chief Scientific Officer |
• • – |
2007-01-26 |
4 |
OE |
$13.29 |
$186,060 |
D/D |
14,000 |
15,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2006-05-04 |
4 |
A |
$2.80 |
$42,000 |
D/D |
15,000 |
98,051 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-15 |
4/A |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
227,471 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
252,171 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-23 |
4 |
S |
$10.50 |
$157,542 |
D/D |
(15,000) |
192,471 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-09-25 |
4 |
AS |
$8.81 |
$134,099 |
D/D |
(15,000) |
60,000 |
0 |
- |
|
63 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
